Geulah Livshits
Stock Analyst at Chardan Capital
(1.95)
# 1,590
Out of 4,502 analysts
131
Total ratings
35.58%
Success rate
n/a
Average return
Main Sectors:
Top Industries:
30 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $38 | $17.94 | +111.82% | 4 | Jul 17, 2024 | |
| LXEO Lexeo Therapeutics | Maintains: Buy | $23 | $11.82 | +94.59% | 2 | Jul 15, 2024 | |
| CRGX CARGO Therapeutics | Initiates: Buy | $28 | $17.34 | +61.48% | 1 | Jul 8, 2024 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $62 | $25.03 | +147.70% | 10 | Jun 28, 2024 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $7 | $2.24 | +212.50% | 9 | Jun 18, 2024 | |
| PRME Prime Medicine | Initiates: Buy | $17 | $5.49 | +209.65% | 1 | Apr 22, 2024 | |
| ACHL Achilles Therapeutics | Maintains: Buy | $11 → $6 | $0.81 | +639.83% | 5 | Apr 5, 2024 | |
| MGX Metagenomi | Maintains: Buy | $21 | $4.63 | +353.56% | 2 | Mar 28, 2024 | |
| TNYA Tenaya Therapeutics | Reiterates: Buy | $20 | $3.80 | +426.32% | 7 | Mar 21, 2024 | |
| IMRX Immuneering | Maintains: Buy | $21 → $16 | $1.15 | +1,291.30% | 6 | Mar 15, 2024 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $110 → $112 | $55.39 | +102.20% | 9 | Feb 22, 2024 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $29 → $34 | $9.13 | +272.40% | 10 | Feb 20, 2024 | |
| SNTI Senti Biosciences | Reiterates: Buy | $6 | $2.27 | +164.32% | 5 | Aug 15, 2023 | |
| MGTX MeiraGTx Holdings | Reiterates: Buy | $41 | $4.56 | +799.12% | 4 | Aug 11, 2023 | |
| IPSC Century Therapeutics | Maintains: Buy | $19 → $17 | $2.38 | +614.29% | 3 | Aug 10, 2023 | |
| KRYS Krystal Biotech | Maintains: Buy | $148 → $153 | $206.64 | -25.96% | 5 | Aug 8, 2023 | |
| PASG Passage Bio | Maintains: Buy | $11 → $9 | $0.83 | +986.43% | 2 | Aug 8, 2023 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $107 | $25.60 | +317.97% | 10 | Aug 7, 2023 | |
| EDIT Editas Medicine | Maintains: Buy | $22 → $19 | $5.34 | +255.81% | 7 | Aug 3, 2023 | |
| IMTX Immatics | Maintains: Buy | $28 → $25 | $12.38 | +101.94% | 2 | Mar 23, 2023 | |
| CABA Cabaletta Bio | Reiterates: Buy | $12 | $6.91 | +73.66% | 4 | Mar 22, 2023 | |
| MRNA Moderna | Maintains: Neutral | $191 → $208 | $118.19 | +75.99% | 7 | Jan 18, 2023 | |
| PDSB PDS Biotechnology | Maintains: Buy | $15 → $16 | $3.77 | +324.97% | 3 | Nov 15, 2022 | |
| LOGC ContextLogic | Maintains: Buy | $4 → $2.5 | $5.74 | -56.45% | 4 | Aug 22, 2022 | |
| SLDB Solid Biosciences | Maintains: Buy | $105 → $90 | $8.84 | +918.10% | 3 | Aug 12, 2022 | |
| RGNX REGENXBIO | Maintains: Buy | n/a | $13.64 | - | 1 | Nov 3, 2021 | |
| VYGR Voyager Therapeutics | Maintains: Neutral | n/a | $8.90 | - | 1 | Nov 3, 2021 | |
| VINC Vincerx Pharma | Maintains: Buy | n/a | $0.66 | - | 2 | Aug 13, 2021 | |
| ADVM Adverum Biotechnologies | Maintains: Neutral | $50 → $30 | $7.87 | +281.19% | 1 | Jul 23, 2021 | |
| IMNM Immunome | Initiates: Buy | n/a | $15.17 | - | 1 | Oct 27, 2020 |
4D Molecular Therapeutics
Jul 17, 2024
Maintains: Buy
Price Target: $38
Current: $17.94
Upside: +111.82%
Lexeo Therapeutics
Jul 15, 2024
Maintains: Buy
Price Target: $23
Current: $11.82
Upside: +94.59%
CARGO Therapeutics
Jul 8, 2024
Initiates: Buy
Price Target: $28
Current: $17.34
Upside: +61.48%
Rocket Pharmaceuticals
Jun 28, 2024
Maintains: Buy
Price Target: $62
Current: $25.03
Upside: +147.70%
Taysha Gene Therapies
Jun 18, 2024
Maintains: Buy
Price Target: $7
Current: $2.24
Upside: +212.50%
Prime Medicine
Apr 22, 2024
Initiates: Buy
Price Target: $17
Current: $5.49
Upside: +209.65%
Achilles Therapeutics
Apr 5, 2024
Maintains: Buy
Price Target: $11 → $6
Current: $0.81
Upside: +639.83%
Metagenomi
Mar 28, 2024
Maintains: Buy
Price Target: $21
Current: $4.63
Upside: +353.56%
Tenaya Therapeutics
Mar 21, 2024
Reiterates: Buy
Price Target: $20
Current: $3.80
Upside: +426.32%
Immuneering
Mar 15, 2024
Maintains: Buy
Price Target: $21 → $16
Current: $1.15
Upside: +1,291.30%
CRISPR Therapeutics AG
Feb 22, 2024
Maintains: Buy
Price Target: $110 → $112
Current: $55.39
Upside: +102.20%
Iovance Biotherapeutics
Feb 20, 2024
Maintains: Buy
Price Target: $29 → $34
Current: $9.13
Upside: +272.40%
Senti Biosciences
Aug 15, 2023
Reiterates: Buy
Price Target: $6
Current: $2.27
Upside: +164.32%
MeiraGTx Holdings
Aug 11, 2023
Reiterates: Buy
Price Target: $41
Current: $4.56
Upside: +799.12%
Century Therapeutics
Aug 10, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $2.38
Upside: +614.29%
Krystal Biotech
Aug 8, 2023
Maintains: Buy
Price Target: $148 → $153
Current: $206.64
Upside: -25.96%
Passage Bio
Aug 8, 2023
Maintains: Buy
Price Target: $11 → $9
Current: $0.83
Upside: +986.43%
Intellia Therapeutics
Aug 7, 2023
Reiterates: Buy
Price Target: $107
Current: $25.60
Upside: +317.97%
Editas Medicine
Aug 3, 2023
Maintains: Buy
Price Target: $22 → $19
Current: $5.34
Upside: +255.81%
Immatics
Mar 23, 2023
Maintains: Buy
Price Target: $28 → $25
Current: $12.38
Upside: +101.94%
Cabaletta Bio
Mar 22, 2023
Reiterates: Buy
Price Target: $12
Current: $6.91
Upside: +73.66%
Moderna
Jan 18, 2023
Maintains: Neutral
Price Target: $191 → $208
Current: $118.19
Upside: +75.99%
PDS Biotechnology
Nov 15, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $3.77
Upside: +324.97%
ContextLogic
Aug 22, 2022
Maintains: Buy
Price Target: $4 → $2.5
Current: $5.74
Upside: -56.45%
Solid Biosciences
Aug 12, 2022
Maintains: Buy
Price Target: $105 → $90
Current: $8.84
Upside: +918.10%
REGENXBIO
Nov 3, 2021
Maintains: Buy
Price Target: n/a
Current: $13.64
Upside: -
Voyager Therapeutics
Nov 3, 2021
Maintains: Neutral
Price Target: n/a
Current: $8.90
Upside: -
Vincerx Pharma
Aug 13, 2021
Maintains: Buy
Price Target: n/a
Current: $0.66
Upside: -
Adverum Biotechnologies
Jul 23, 2021
Maintains: Neutral
Price Target: $50 → $30
Current: $7.87
Upside: +281.19%
Immunome
Oct 27, 2020
Initiates: Buy
Price Target: n/a
Current: $15.17
Upside: -